COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01637532
Brief Title: Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer (PITCH)

First Submitted : April 15, 2012
First Submitted that Met QC Criteria : July 8, 2012
First Posted : July 11, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : January 25, 2016
Last Update Posted : January 26, 2016 (Estimate)